AMPA receptor modulators (Pfizer)

N/A

Report date: 2025/03/17 20:00:36

NME

Base Information

Drug NameAMPA receptor modulators (Pfizer)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists

TargetsGlutamate receptor ionotropic AMPA

Therapy Area/IndicationsCognition DisordersNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsCognition DisordersNervous System Diseases

ATC CodeN/A